Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-24 @ 4:04 PM
Study NCT ID:
NCT04460066
Status:
UNKNOWN
Last Update Posted:
2022-05-04
First Post:
2020-07-01
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Sponsor:
Lee's Pharmaceutical Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-01
First Submit QC Date:
None
Study First Post Date:
2020-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-28
Last Update Post Date:
2022-05-04
Last Update Post Date Type:
ACTUAL